|
Volumn 414, Issue 6860, 2001, Pages 160-161
|
Microbiology: Tackling anthrax
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBIOTICS;
DISEASES;
ANTIBIOTIC DEVELOPMENT;
MICROBIOLOGY;
ACTIVATED PROTEIN C;
ANTHRAX VACCINE;
ANTIBIOTIC AGENT;
ANTITOXIN;
BACTERIUM ANTIBODY;
CYTOKINE;
ENZYME INHIBITOR;
MUTANT PROTEIN;
PROTEIN INHIBITOR;
TOXIN ANTIBODY;
ANTHRAX TOXIN;
ANTHRAX TOXIN RECEPTORS;
BACTERIAL ANTIGEN;
BACTERIAL TOXIN;
RECEPTOR;
MICROBIOLOGY;
ANTHRAX;
ANTIBIOTIC THERAPY;
BACILLUS ANTHRACIS;
BACTERIAL GENETICS;
BIOLOGICAL WARFARE;
HUMAN;
INFECTION CONTROL;
MICROBIOLOGY;
NONHUMAN;
PRIORITY JOURNAL;
SHORT SURVEY;
TOXIN STRUCTURE;
VACCINE PRODUCTION;
BACTERIAL GENOME;
BACTERIAL SPORE;
CHEMISTRY;
DRUG ANTAGONISM;
GENETICS;
IMMUNOLOGY;
NOTE;
PHYSIOLOGY;
PROTEIN CONFORMATION;
ANTHRAX;
BACILLUS ANTHRACIS;
BACTERIA (MICROORGANISMS);
ANTHRAX;
ANTIBODIES, BACTERIAL;
ANTIGENS, BACTERIAL;
ANTITOXINS;
BACILLUS ANTHRACIS;
BACTERIAL TOXINS;
BIOTERRORISM;
GENOME, BACTERIAL;
HUMANS;
PROTEIN CONFORMATION;
RECEPTORS, PEPTIDE;
SPORES, BACTERIAL;
|
EID: 0035829555
PISSN: 00280836
EISSN: None
Source Type: Journal
DOI: 10.1038/35102660 Document Type: Short Survey |
Times cited : (59)
|
References (11)
|